Immediate Impact
14 from Science/Nature 73 standout
Citing Papers
Tumour vasculature at single-cell resolution
2024 StandoutNature
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of James M. Cleary being referenced
1315MO Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) non-small cell lung cancer (NSCLC)
2023
Efficacy and safety of atezolizumab (atezo) and bevacizumab (bev) in a phase Ib study of microsatellite instability (MSI)-high metastatic colorectal cancer (mCRC).
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| James M. Cleary | 1915 | 1012 | 774 | 1368 | 152 | 3.6k | |
| Zhongwu Li | 1576 | 925 | 632 | 1151 | 176 | 3.2k | |
| Michio Sowa | 1353 | 933 | 782 | 1644 | 183 | 3.4k | |
| Benjamin Goeppert | 1240 | 930 | 1089 | 864 | 103 | 2.9k | |
| Kaoru Tanaka | 2191 | 1329 | 341 | 1091 | 110 | 3.6k | |
| Stefano Pepe | 2468 | 1050 | 476 | 2577 | 129 | 5.2k | |
| Soomin Ahn | 1130 | 615 | 498 | 745 | 129 | 2.5k | |
| Tetsuji Sawada | 1439 | 1090 | 614 | 1792 | 164 | 5.0k | |
| Nobuhiko Tanigawa | 1731 | 1992 | 1600 | 1462 | 176 | 5.3k | |
| David F. Schaeffer | 1488 | 580 | 795 | 942 | 140 | 3.1k | |
| Colin D. Weekes | 2040 | 607 | 328 | 1336 | 139 | 3.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...